RealFeedApp beta

Drug Enhertu strengthens immune memory against cancer

A Regeneron study found that mice whose tumors disappeared survived weeks after re-injection with the same cancer cells. The immune memory mechanism protected them without further treatment.

Field
drugs and trials
What they did
Researchers combined an existing cancer drug, Enhertu, with an experimental antibody in mice. This combination completely eliminated tumors, after which the animals remained resistant to re-injection of the same cancer cells for weeks without further treatment.
Why it matters
This approach could benefit patients by leveraging the immune system's memory to recognize and attack cancer cells repeatedly, potentially extending survival after remission.
#immunotherapy#cancer#regeneron#tumor#memory

Read the original →